Success Story: NIW Approved Without RFE! Pakistani Associate Professor Achieves Success with Our Strategic Support
Client’s Testimonial:
“Thank you so much for sharing such wonderful and exciting news with me. I’m absolutely thrilled and incredibly grateful! I truly appreciate the exceptional professional support you provided throughout every stage of my NIW immigration process. From the very beginning, your guidance, clear communication, and attention to detail gave me confidence and peace of mind. Your expertise helped simplify what could have been an overwhelming process, and your responsiveness and encouragement made a significant difference. I especially want to acknowledge your consistent dedication, timely updates, and thoughtful handling of every part of my case. Your role in this successful outcome has been invaluable, and I am sincerely thankful for your efforts.”
On April 15th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Professor in the Field of Pharmaceutical Sciences (Approval Notice).
General Field: Pharmaceutical Sciences
Position at the Time of Case Filing: Associate Professor
Country of Origin: Pakistan
Country of Residence at the Time of Filing: Pakistan
Approval Notice Date: April 15th, 2025
Processing Time: 1 year, 4 months, 2 days
Case Summary:
We are pleased to share the recent I-140 National Interest Waiver (NIW) approval for a highly accomplished PhD holder originally from Pakistan. This milestone highlights not only our client’s outstanding contributions to pharmaceutical sciences but also the power of a well-structured petition in securing immigration benefits for researchers working on projects of national significance.
Research Focus and Impact
Our client’s work lies at the intersection of pharmacology and natural product research, with a focus on developing non-synthetic therapeutic options for treating inflammation-related disorders, neurological diseases, chronic pain, and systemic conditions. By exploring bioactive compounds derived from traditional medicinal plants and leveraging innovative analytical methods, our client has built a compelling record of impactful research aimed at improving patient outcomes.
His future plans include designing natural compound-based therapeutics through computer-aided drug discovery, with an emphasis on treating Type 1 diabetes and neurological disorders – areas that represent significant public health concerns in the U.S.
Petition Category and Evidence of Excellence
The petition strategically demonstrated our client’s qualifications through:
● A robust publication record, including nearly 100 peer-reviewed journal articles and several book chapters,
● Over 3,400 citations, with numerous publications ranked among the most-cited papers in the field of Pharmacology & Toxicology for their publication years,
● At least 19 verified peer review assignments for leading journals in pharmacology, neuroscience, nanomedicine, and toxicology,
● Editorial board memberships with reputable journals, reflecting leadership and trust in his expertise,
● Research funding from major international institutions and government agencies underlines the global recognition of his work.
Letters of Recommendation
Two independent experts in pharmaceutical and medical research provided letters of recommendation, attesting to the originality and national value of the client’s work. Their statements strengthened the case for a waiver of the labor certification requirement based on national interest.
“It is clear that [Client] is an exceptional researcher at the top of the field of pharmaceutical sciences. His history of successful project outcomes is indicative of a uniquely skilled scientist. In addition, his work on identifying the neuroprotective and pain-relieving effects of natural products has provided others within the field with essential guidance for the development of new pharmaceuticals.”
Client’s Reflection on the Process
“I am delighted to share the exciting news of my National Interest Waiver (NIW) approval, and I would like to extend my heartfelt thanks to Chen Immigration Law Associates for their outstanding support and expertise throughout this journey.
As a researcher in the field of pharmaceutical sciences, I knew that preparing a successful NIW petition would require not only a strong presentation of my academic and research credentials but also an in-depth understanding of the complex immigration process. From the initial evaluation to the final approval, the Chen Immigration team demonstrated exceptional professionalism, clarity, and efficiency.
Their ability to translate technical details into a compelling legal argument was truly impressive. Thank you, Chen Immigration Law Associates, for making my NIW approval a reality.”
This approval highlights the critical role of research in natural therapeutics for national health priorities and exemplifies how targeted legal strategy and scientific excellence can come together to secure immigration benefits. We look forward to seeing our client’s continued contributions in the pharmaceutical and public health sectors.